The membrane-proximal-domain FcRH5 binder demonstrated the strongest in vitro functionality; however, a membrane-distal binder mediated similar tumor cell killing when the epitope was moved to a membrane-proximal position through genetic engineering [61]. Here, FCRL5 is linked to neoplasm.